Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) | PAR 25 255

Frequently Asked Questions (FAQs) - NIH R01 PAR-25-255: Methods and Theory for the Genetic Architecture of Complex Human Traits

1) What is this funding opportunity?

This is a National Institutes of Health (NIH) invitation to submit R01 grant applications under PAR-25-255. The opportunity supports research that develops new theory and methodological approaches to improve how researchers understand the genetic architecture of complex human traits.

2) What is the main goal of PAR-25-255?

The central goal is to advance the conceptual and analytic toolkit used to explain why traits and outcomes vary across individuals, families, and populations. The focus is on building and validating better models and methods, not on running clinical trials.

3) Is this opportunity focused on clinical trials?

No. The provided description emphasizes theory, modeling, and methods development rather than clinical trials. Projects are expected to push forward conceptual and analytic approaches for complex trait research.

4) What kinds of research does NIH want to fund under this announcement?

NIH is seeking projects that develop new statistical frameworks, computational methods, or conceptual models that clarify how genetic factors operate alone and in combination with non-genetic influences (such as social environments, ecological contexts, and other exposures and experiences). Strong applications typically propose a methodological advance and then rigorously validate it using real, existing large-scale datasets.

5) What does NIH mean by "complex human traits" in this context?

In this opportunity, "complex" is taken literally: traits and outcomes arise from many genes and many environments, with influences that can cluster and correlate within families, communities, and broader populations. NIH is looking for approaches that better represent that multi-factor, multi-level reality.

6) How important is interdisciplinarity for PAR-25-255?

Interdisciplinarity is a major emphasis. NIH is looking for projects that draw meaningfully from both natural sciences (for example, genetics, genomics, computational biology, epidemiology, ecology, evolutionary biology) and social sciences (for example, sociology, demography, economics, psychology, social epidemiology).

7) What does "multi-scale" or "multiple levels of organization" mean here?

The announcement encourages applicants to recognize that influences on complex traits can be interdependent across scales, such as molecular processes, individual development, family structure, community conditions, and broader population patterns. Applicants are encouraged to model connections across these levels, including feedback loops and correlations across levels.

8) Are gene-environment processes within scope?

Yes. The scope supports work that better captures gene-environment interplay, including how genetic factors interact with social and ecological contexts and other layers of exposure and experience.

9) Are projects expected to use real datasets, or can they be purely theoretical?

The description strongly emphasizes rigorous validation using existing large-scale datasets. Competitive applications will typically develop new methods or models and then demonstrate performance and usefulness by testing them with available large datasets (for example, large cohorts, biobanks, multigenerational family data, or population-scale resources).

10) What kinds of datasets are mentioned as good fits for validation?

Examples named include large cohorts, biobanks, multigenerational family data, and population-scale resources. The overall expectation is that methods should be grounded in real data and stress-tested in realistic settings.

11) What does NIH mean by "rigorous validation" and "stress-testing"?

Based on the description provided, NIH expects methods to be evaluated for robustness, interpretability, bias, and generalizability across settings and populations. In practical terms, this means demonstrating that the proposed approach works reliably under realistic conditions and across different samples or contexts.

12) Is disentangling genetic effects from environmental and social confounding part of the scope?

Yes. The scope explicitly supports work that helps disentangle genetic effects from environmental and social confounding and improves causal inference in complex trait research.

13) Are family relationships and population structure considered in scope?

Yes. The opportunity supports work that better captures structured population and family relationships, including correlations and dependencies that occur across individuals within families and across populations.

14) What is the funding mechanism for this opportunity?

The funding instrument is a grant using the NIH R01 mechanism (Funding Instrument: Grant). The activity category is listed as Education, Health.

15) What are the CFDA numbers associated with this opportunity?

The CFDA numbers listed are 93.172, 93.242, and 93.399.

16) When was this opportunity created?

The opportunity was created on 2024-11-15.

17) What is the application due date (closing date) shown in the provided information?

The original application due date (closing date) listed is 2026-11-05.

18) Does the provided information list an award ceiling or expected number of awards?

No. The provided source data does not list an award ceiling or the expected number of awards. Typically, that means applicants should refer to the full NOFO text and standard NIH R01 budgeting policies and institute-specific guidance for budget expectations and award details.

19) Who is eligible to apply?

Eligibility is broad and includes many types of U.S. organizations and governmental units, including state, county, city/township, and special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses.

20) Are minority-serving institutions and community-based organizations eligible?

Yes. The NOFO highlights additional eligible applicant categories including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs), as well as faith-based or community-based organizations.

21) Are U.S. territories or regional organizations eligible?

Yes. The NOFO highlights U.S. territories or possessions and regional organizations among eligible applicant categories.

22) Are non-U.S. (foreign) organizations eligible to apply?

Yes. The NOFO explicitly includes non-U.S. entities (foreign organizations) among eligible applicants, subject to NIH rules and alignment with the scope of the announcement.

23) What types of disciplines are explicitly encouraged?

The opportunity encourages meaningful integration across natural sciences (for example, genetics, genomics, computational biology, epidemiology, ecology, evolutionary biology) and social sciences (for example, sociology, demography, economics, psychology, social epidemiology).

24) What is NIH trying to improve in the field with this program?

NIH is trying to improve how the field explains variation in human traits across diverse populations and contexts by supporting next-generation models and methods that better represent the intertwined roles of genetics, environments, families, and social structures.

25) What would a competitive application generally look like based on the description provided?

Based on the information provided, a competitive application would typically (1) propose a new methodological or theoretical framework (statistical, computational, or conceptual), (2) explicitly address multi-level and interdependent influences on complex traits, and (3) validate the approach using existing large-scale datasets, with careful evaluation of robustness, interpretability, bias, and generalizability.